EquityBulls

Latest News

Keywords Selected: Phase3

Stock Report

CuraTeQ Biologics announces Positive Top-Line Results for Phase 3 Study of Omalizumab Biosimilar BP11
Tejas Networks completes delivery of 17,000 IP/MPLS routers for BharatNet Phase III
Sumeet Industries announces ₹23.47 Cr Acquisition to Strengthen Polyester Chips Capacity
Phase III Clinical Trial of DengiAll® by ICMR and Panacea Biotec - Completion of enrollment of study participants
Tejas Networks emerges as a leading supplier of IP Routing products across the country for BharatNet Phase III packages
Brigade Enterprises Ltd acquires 4.04 acres in Neopolis Phase 3 Auction
THE LANCET Regional Health publishes Pivotal Phase 3 Clinical Study on Miqnaf®
CuraTeQ Biologics Pvt Ltd completes Phase 3 Clinical Study for Denosumab Biosimilar
Sun Pharma's Phase 3 Clinical Studies Evaluating Tildrakizumab 100 mg in Active Psoriatic Arthritis Meet their Primary Endpoint
HFCL Ltd bags order aggregating to ~INR 157 Crores from Tera Software Ltd
ITI Limited initiates State Network Operations Center for BharatNet Phase-III Project in Himachal Pradesh
Birla Estates secures landmark booking value of approx INR 500cr for 3rd consecutive time with Phase 3 of Birla Trimaya in Bengaluru
Indian Regulatory Authority - SEC approval for conducting Phase III Clinical trials for Recombinant Human Albumin (rHA) 20%
Shilpa Medicare announces successful outcome of Phase 3 studies of SMLNUD07 - NorUDCA
Results of the Phase III PIVOTAL trial of Nidlegy in melanoma to be presented at ASCO 2024
Brigade Enterprises Ltd launches Brigade Oasis Phase-3
Wockhardt announces successful completion of pivotal Phase 3 pneumonia study of its macrolide antibiotic Nafithromycin WCK 4873
Nidlegy™ Phase III PIVOTAL trial meets the study's primary objective
CuraTeQ Biologics announces positive result in phase 3 clinical trial for its proposed Trastuzumab Biosimilar product
Suven Life Sciences announces Randomization of First Patient in Phase-3 Global Clinical Trial of Masupirdine
Shilpa Medicare completes Human Clinical Studies of High Concentration Biosimilar Adalimumab
Wockhardt announces successful initiation of Global Phase 3 Clinical Study of its novel antibiotic WCK 5222
Glenmark Pharma and SaNOtize announce Peer Reviewed Publication of its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray
The Lancet publishes Phase III data of ZyCoV-D